GHIT Fund Progress Hailed But Much To Do
This article was originally published in PharmAsia News
Executive Summary
The Japan-based GHIT Fund was set up just over two years ago to accelerate the development of drugs, vaccines and diagnostics for malaria, tuberculosis and other neglected infectious diseases affecting developing countries by building on Japan's science and research capabilities. While good progress has been made, political support and a sense of urgency are required to ensure continued impact.